Literature DB >> 2229344

Beta 2-microglobulin and neopterin: predictive markers for human immunodeficiency virus type 1 infection in children?

M M Chan1, J M Campos, S Josephs, N Rifai.   

Abstract

The value of beta 2-microglobulin and neopterin concentrations in serum for early diagnosis of infants born to human immunodeficiency virus type 1 (HIV-1)-infected mothers was assessed. Concentrations of both markers were measured in serum samples from pediatric patients (Centers for Disease Control classifications P0, P1, and P2), as well as in age-matched normal subjects. Both beta 2-microglobulin and neopterin were significantly increased in HIV-1-infected symptomatic subjects (P2) compared to controls. Seventy-five percent of asymptomatic patients (P1) also had increased values. On the other hand, a significant overlap in concentrations of both markers in serum was found between controls and P0 patients. Thirty-eight percent of the P0 patients had values comparable to those of the P2 group. Persistently high concentrations of both markers in P0 patients may be indicative of HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2229344      PMCID: PMC268150          DOI: 10.1128/jcm.28.10.2215-2219.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  Soluble IL-2 receptor levels in serum from blood donors seropositive for HIV.

Authors:  H E Prince; S Kleinman; A E Williams
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

2.  Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  Urinary neopterin in the diagnosis of acquired immune deficiency syndrome.

Authors:  D Fuchs; A Hausen; G Reibnegger; H Reissigl; D Schönitzer; T Spira; H Wachter
Journal:  Eur J Clin Microbiol       Date:  1984-02       Impact factor: 3.267

4.  Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy.

Authors:  E DeStefano; R M Friedman; A E Friedman-Kien; J J Goedert; D Henriksen; O T Preble; J A Sonnabend; J Vilcek
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

5.  Quantitation of beta 2-microglobulin and other immune characteristics in a prospective study of men at risk for acquired immune deficiency syndrome.

Authors:  S Zolla-Pazner; D William; W El-Sadr; M Marmor; R Stahl
Journal:  JAMA       Date:  1984-06-08       Impact factor: 56.272

6.  Elevated beta 2-microglobulin and lysozyme levels in patients with acquired immune deficiency syndrome.

Authors:  M H Grieco; M M Reddy; H B Kothari; M Lange; E Buimovici-Klein; D William
Journal:  Clin Immunol Immunopathol       Date:  1984-08

Review 7.  Immunologic abnormalities in the acquired immunodeficiency syndrome.

Authors:  H C Lane; A S Fauci
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

8.  Immunologic abnormalities in the acquired immunodeficiency syndrome (AIDS).

Authors:  A S Fauci
Journal:  Clin Res       Date:  1984-12

9.  Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders.

Authors:  J L Fahey; H Prince; M Weaver; J Groopman; B Visscher; K Schwartz; R Detels
Journal:  Am J Med       Date:  1984-01       Impact factor: 4.965

10.  Critical analysis of T cell subset and function evaluation in patients with persistent generalized lymphadenopathy in groups at risk for AIDS.

Authors:  M Cavaille-Coll; A Messiah; D Klatzmann; W Rozenbaum; D Lachiver; S Kernbaum; E Brisson; F Chapuis; C Blanc; P Debre
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

View more
  3 in total

1.  Neopterin in diagnosis of human immunodeficiency virus infection in infants.

Authors:  J Rautonen; N I Martin; N Rautonen; D W Wara
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

2.  Increase in dendritic cell numbers, their function and the proportion uninfected during AZT therapy.

Authors:  M Gompels; S Patterson; M S Roberts; S E Macatonia; A J Pinching; S C Knight
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

Review 3.  Laboratory methods for early detection of human immunodeficiency virus type 1 in newborns and infants.

Authors:  A V Sison; J M Campos
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.